Patents by Inventor Klemens Vierlinger

Klemens Vierlinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200010911
    Abstract: The invention relates to a method of distinguishing a thyroid cancer type or risk thereof, comprising the step of determining the DNA methylation status of thyroid cancer genes of a sample of a subject, wherein the thyroid cancer genes are selected from one or more of the genes of table 1 or 2, and comparing the methylation status of said genes with a control sample, thereby identifying thyroid cancer DNA in the sample.
    Type: Application
    Filed: August 1, 2019
    Publication date: January 9, 2020
    Inventor: Klemens Vierlinger
  • Publication number: 20190094228
    Abstract: A method is provided of diagnosing prostate cancer or the risk of prostate cancer in a patient by detecting antibodies against the following marker proteins or a selection of at least 2 or at least 20% of the marker proteins of any List provided herein in a patient, including the step of detecting antibodies binding the marker proteins in a sample of the patient; and systems and kits for such methods.
    Type: Application
    Filed: March 3, 2017
    Publication date: March 28, 2019
    Inventors: Johana Andrea LUNA, Klemens VIERLINGER, Christa NOEHAMMER, Regina SOLDO, Magdalena GAMPERL, Lisa MILCHRAM, Andreas WEINHÄUSEL
  • Patent number: 10100364
    Abstract: The present invention provides a set of moieties specific for tumor markers, in particular of follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) as well as a method for identifying markers of any genetic disease.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: October 16, 2018
    Assignee: AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH
    Inventors: Klemens Vierlinger, Martin Lauss, Albert Kriegner, Christa Noehammer
  • Publication number: 20180051343
    Abstract: The invention relates to a method of distinguishing a thyroid cancer type or risk thereof, comprising the step of determining the DNA methylation status of thyroid cancer genes of a sample of a subject, wherein the thyroid cancer genes are selected from one or more of the genes of table 1 or 2, and comparing the methylation status of said genes with a control sample, thereby identifying thyroid cancer DNA in the sample.
    Type: Application
    Filed: August 10, 2015
    Publication date: February 22, 2018
    Inventor: Klemens VIERLINGER
  • Publication number: 20170283887
    Abstract: The present invention relates to specifically methylated nucleic acids, methods of diagnosing lung cancer or a predisposition therefor, and a corresponding kit.
    Type: Application
    Filed: November 24, 2015
    Publication date: October 5, 2017
    Inventors: Matthias Wielscher, Andreas Weinhäusel, Klemens Vierlinger, Christa Noehammer, Rolf Ziesche, Andrea Gsur
  • Publication number: 20150252437
    Abstract: The present invention provides a set of moieties specific for tumor markers, in particular of follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) as well as a method for identifying markers of any genetic disease.
    Type: Application
    Filed: April 20, 2015
    Publication date: September 10, 2015
    Applicant: AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH
    Inventors: Klemens Vierlinger, Martin Lauss, Albert Kriegner, Christa Noehammer
  • Publication number: 20110152110
    Abstract: The present invention provides a set of moieties specific for tumor markers, in particular of follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) as well as a method for identifying markers of any genetic disease.
    Type: Application
    Filed: August 29, 2008
    Publication date: June 23, 2011
    Applicant: AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH
    Inventors: Klemens Vierlinger, Martin Lauss, Albert Kriegner, Christa Noehammer